Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol for laryngoscopic exposure with preserved spontaneous breathing in cervical spine surgery
ChiCTR2400086137Phase 4Not yet recruiting
- Sponsor
- Peking University Third Hospital
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Neck disorders comparing Remimazolam besylate group with Propofol group (2 arms). Primary endpoints: Respiratory rate and SpO2. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
remimazolampropofol
03
Conditions
Neck disorders
Beyond the preview
Go deeper on ChiCTR2400086137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400086137.